Publication Month: Mar 2022 | Report Code: TIPRE00027427 | No. of Pages: 158 | Category: Medical Device | Status: Published
An organ care product is a medical device used to preserve donor organs for longer periods before transplantation. These procedures allow the transplant team to ensure that transplant organs function optimally. It is a technique for keeping transplanted or donor organs at a safe temperature. "Heart in a box" is another name for this technique. Before being transplanted, organs of interest are kept in the best possible condition and are entirely manageable. The approach confers with the traditional systems of preserving organs by freezing or running them in an environment and condition comparable to that of the human body by perfusing the donor's blood via the organs. Organs like the kidney, liver, heart, and lungs can be monitored from this technology to ensure that they function at their best. Organ care products contain one or more pump units, thermo units, and trolleys.
The organ care products market is segmented based on modality, organ type, end user, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The organ care products report offers insights and in-depth analysis of the market, emphasizing parameters such as market trends, technological advancements, market dynamics, and the competitive analysis of the globally leading market players.
|Market Size Value in||US$ 98.46 million in 2021|
|Market Size Value by||US$ 272.16 million by 2028|
|Growth rate||CAGR of 15.6% from 2021 to 2028.|
|Forecast Period||2021- 2028|
|No. of Pages||158|
|No. of Tables||84|
|No. of Charts & Figures||74|
|Historical data available||Yes|
|Segments covered||Modality, Organ Type, and End User, and Geography|
|Regional scope||North America, Europe, Asia Pacific, Middle East & Africa, South & Central America|
|Country scope||US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina|
|Report coverage||Revenue forecast, company ranking, competitive landscape, growth factors, and trends|
|Free Sample Copy Available|
Get more information on this report :
The rising demand for organ transplantation due to organ failure has boosted the requirement for organ care products. The fast-changing healthcare dynamics and rising prevalence of organ failure and donation have created the demand for effective organ care products. In response to such prominent demand, various market players focus on offering better organ care products to fulfill the market demand. In addition, the approvals of such products from regulatory bodies allow the safe storage and transportation of donor organs over long distances, which is expected to contribute to the growth of the organ care products market.
Following are a few examples of companies that launched new products and approvals for organ care products:
• In October 2021, Paragonix Technologies clinically and commercially launched the LIVERguard Donor Liver Preservation System in the US and Europe, along with its global clinical registry Global Utilization and Registry Database for Improved preservation of donor LIVERs (GUARDIAN-LIVER). The system was designed for consistent and repeatable standardized cold storage of livers, regardless of time, geography, or unforeseen conditions.
• In September 2021, TransMedics Group, Inc. announced the USFDA premarket approval for its OCS Liver System to preserve organs after DBD and DCD. The system is used to preserve and monitor hemodynamics and metabolic function, which allows for ex-vivo assessment of liver allografts from DBD and DCD donor livers based on the OCS Liver PROTECT Trial.
Such developments by market players are driving the organ care products market.
Based on modality, the global organ care products market is segmented into trolley and portable. In 2021, the trolley segment held a larger share of the market. Moreover, the portable segment is expected to register a higher CAGR in the market during 2021–2028. This is mainly due to the convenience and compactness of organ care products. The portable devices help manage time during organ storage and improve organ quality.
Based on organ type, the global organ care products market is segmented into kidney, liver, heart, lungs, and others. In 2021, the kidney segment held the largest market share. However, the lungs segment is expected to register the highest CAGR during 2021–2028. The growth of the kidney segment is attributed to the rising incidence of kidney failure that leads to a massive number of patients on a waiting list. As per the data by Health Resources & Services Administration, in 2020, nearly 91,099 patients required kidney transplants in the US. With the growing number of patients suffering from chronic conditions, the demand for organ care products will increase in the coming years.
Get more information on this report :
Based on end user, the global organ care products market is segmented into hospitals, ambulatory surgical centers, and others. In 2021, the hospitals segment held the largest share of the market. Moreover, the same segment is expected to register the highest CAGR in the market during 2021–2028. The increasing incidence of organ failure worldwide, leading to organ transplants, drives the segment. According to OPTN data, total transplants from 1998 till January 2022 accounted for 881,082. 518,946 were kidney transplants, 191,894 liver transplants, and 83,643 were heart transplants among others.
Product launches and collaborations are highly adopted strategies by the global organ care products market players. A few of the recent key market developments are listed below:
In February 2021, Bridge to Life, Ltd. and Tevosol, Inc. merged to develop and commercialize groundbreaking new products for the organ transplantation community. The arrangement includes Bridge to Life's significant financial commitment to manufacture, trial, and launch Tevosol's portable ex-vivo lung perfusion (EVLP) machine and normothermic organ preservation platform.
In June 2019, TransMedics announced the Second FDA PMA Approval for its OCS Lung System, allowing access to a larger pool of donor's lungs that are currently seldomly utilized for transplantation due to limitations of cold storage.
The COVID-19 pandemic has highly impacted organ donation and transplantation globally and affected the execution of life-saving procedures such as organ transplantation by altering the process of organ donation and recovery. Moreover, it has disrupted the donation and transplant activities worldwide, leading to a decline in the demand for organ care products. The transplants from deceased donors were limited to only urgent situations, and transplants from living donations were put on hold. This resulted in lost opportunities for a large number of vulnerable patients on transplant waiting lists. In addition, a decrease in the number of potential deceased organ donors, a saturation of healthcare systems and ICU capacities, limited access to donor and recipient testing for the infection, and challenges in travel/transport logistics for retrieval teams and donated organs were also observed. That impacted the market negatively during the pandemic period.
However, the pandemic led to the implementation of new practices for adequate donor evaluation and consent, organ recovery, and organ procurement organization, which will help the market grow significantly in the future.
The global organ care products market is segmented based on modality, organ type, end user, and geography. In terms of modality, the market is segmented into trolley and portable. Based on organ type, the organ care products market is segmented into kidney, liver, heart, lungs, and others. In terms of end user, the organ care products market is segmented into hospitals, ambulatory surgical centers, and others. Geographically, the market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South and Central America.